Figure 2From: Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer High expression of PODXL protein is associated with a poor outcome in colorectal cancer patients. Kaplan-Meier analyses of (A) 5-year OS in cohort 1, (B) TTR and (C) DFS in cohort 2 according to PODXL expression.Back to article page